Literature DB >> 3939515

Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens.

A Giammanco, R Di Stefano, S Arista, A Sinatra, A Chiarini.   

Abstract

Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for "in-house" investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geographical area and to obtain indications about the more appropriate composition of polyvalent anti-Pseudomonas vaccines. In the present report, we describe the relatively high frequency of isolation of serogroup 12 from patients in Palermo, Italy. Serogroup 12 is very rare in north-Europe and in the USA, and, as a consequence, it is not included in some vaccine preparations. In Palermo, strains belonging to this serogroup, resistant to a large number of antibiotics, were on the contrary isolated, during more than six years, in different hospitals and from three out-patients. In a Burns Unit, they were in particular responsible for extensive and life-threatening outbreaks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939515     DOI: 10.1007/bf00141801

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  Development of immunotherapy for infections due to Pseudomonas aeruginosa.

Authors:  M W Fisher
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 3.  [Typing of strains of Pseudomonas aeruginosa isolated in Palermo].

Authors:  D Natoli; A Giammanco; P Varvaro; S Teresi; M Menozzi; A Chiarini
Journal:  Ann Sclavo       Date:  1981 May-Jun

4.  [Serological typing of strains fo Pseudomonas aeruginosa. I. Clinical and epidemiological considerations].

Authors:  P Berti; B Maranini; P Mazzoni
Journal:  Ann Sclavo       Date:  1980 Jul-Aug

5.  [Evaluation of biochemical, serological and antibiotic-sensitivity characteristics of Pseudomonas aeruginosa for epidemiological purpose].

Authors:  V Chiaradia; M Crovatto; G Marchetti; E Basaglia; G Santini; E Grattoni
Journal:  Ann Sclavo       Date:  1982 Mar-Apr

6.  Active immunoprophylaxis in burns with a new multivalent vaccine.

Authors:  A Sachs
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

7.  Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations.

Authors:  R B Lindberg; R L Latta
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

8.  Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

Authors:  M R Moody; V M Young; D M Kenton; G D Vermeulen
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

9.  Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification.

Authors:  O S Mikkelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

10.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

View more
  6 in total

1.  Study of Pseudomonas aeruginosa serotype O12 isolates with a common antibiotic susceptibility pattern.

Authors:  A Talarmin; P Dubrous; P Gérome; Y Buisson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

2.  Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections.

Authors:  P Visca; F Chiarini; A Mansi; C Vetriani; L Serino; N Orsi
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982.

Authors:  D Allemeersch; J Beumer; M Devleeschouwer; S De Maeyer; J Dony; C Godard; P Osterrieth; A Pithsy; P Van der Auwera; H Van Poppel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Multiresistant serotype O 12 Pseudomonas aeruginosa: evidence for a common strain in Europe.

Authors:  T L Pitt; D M Livermore; D Pitcher; A C Vatopoulos; N J Legakis
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa.

Authors:  A Tsakris; A C Vatopoulos; L S Tzouvelekis; N J Legakis
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

6.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.